̽»¨¾«Ñ¡

• 2025, Professor of Pediatric endocrinology, Department of Women's and Children's Health, ̽»¨¾«Ñ¡, Stockholm, Sweden
• 2022, Professor of Pediatrics, University of Gothenburg, Gothenburg, Sweden
• 2022, Adjunct Professor of Pediatric endocrinology and inherited metabolic diseases, Department of Women's and Children's Health, ̽»¨¾«Ñ¡, Stockholm, Sweden
• Senior Consultant, Pediatric Endocrinology and Metabolic Diseases,  Karolinska University Hospital, Stockholm, Sweden
• European Pediatric Chair, Main thematic group — Adrenal, Endo-ERN
  
  

We are investigating cognitive functioning and brain development in children and adults with rare endocrine diseases (CAH, Addisons), and other inborn errors of metabolism (IEM) included in the neonatal screening program. We investigate which factors affect cognitive and brain development, so that we can improve treatment and maintain brain health as much as possible. The project also aims to describe somatic health outcomes, quality of life and  natural progression of disease in children and adults with IEM in Sweden prior to and after the introduction of the expanded neonatal screening program for IEM. Ultimately the aim is to offer better help to patients in the future if more targeted and timely interventions can be developed based on increased understanding of their problems. We also have a long-running project on prenatal treatment with dexamethasone in CAH, in which we follow patients from foetal stage to adulthood and assess metabolic, cognitive, neural and epigenetic long-term effects.